United States· US:0527-1368_399a377e-237d-4939-ad70-805ebd30a1c9

Danazol

A danazol product containing danazol, registered in United States by Lannett Company, Inc.. The same ATC class is registered in 9 of our 19 countries.

ATC G03XA01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDanazolATCG03XA01REGISTER NO.US:0527-1368_399a377e…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Danazol is registered in 9 of 19 countries.

Countries holding a registration under ATC G03XA01 (danazol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose

Danazol · ATC G03XA01

9 / 19 countries

  • Canada
  • Finlandprice
  • Franceprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of danazol costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Danazol · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • ES Spain$2.29
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DANAZOL
Manufacturer
Lannett Company, Inc.
Country
United States (US)
ATC code
G03XA01
ATC class
Danazol
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0527136801
    100 CAPSULE in 1 BOTTLE (0527-1368-01)
  • ndc11
    0527-1368-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

197 interactions on record for danazol.

Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Danazol · interactions on record

197 records

  • 13 severe
  • 153 moderate
  • 7 minor
  • 21 info

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Danazol in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All danazol products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Cyprus · Anargil
  • Spain · Danatrol
  • France · Danatrol
  • United Kingdom (Northern Ireland) · Danazol Generics Uk
  • Italy · Danatrol
  • Netherlands · Danatrol
  • Poland · Danazol Polfarmex
  • Slovakia · Anargil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b74e9f20-eb13-44d4-a345-e61ecdbc3eb5
GET /v1/drugs/b74e9f20-eb13-44d4-a345-e61ecdbc3eb5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "100",
  "substance": "DANAZOL",
  "productndc": "0527-1368",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA078214",
  "marketing_category": "ANDA"
}

See everything about danazol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.